Fusion Antibodies is a CRO that offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development.
Latest News
-
Grant of U.S. Patent for OptiMAL®
05 August 2025 -
Issue Notification: US Patent Update
24 July 2025 -
Director/PDMR Shareholding
11 July 2025
Investor Alert
Sign up for Investor Alerts »